Compound Detail
CHEMBL4072833
EVOBRUTINIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL4072833 |
| Name | EVOBRUTINIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | QUIWHXQETADMGN-UHFFFAOYSA-N |
12
Targets
31
Activities
3
Assay Types
10
PK Parameters
20
Publications
5
Known Names
6
Indications
1
Mechanisms
Molecular Properties
429.5
MW (Da)
4.35
ALogP
6
HBA
2
HBD
93.4
PSA (Ų)
0.54
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase BTK inhibitor | INHIBITOR | Tyrosine-protein kinase BTK | ✓ | ✓ |
Indications
Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting Arthritis, Rheumatoid Lupus Erythematosus, Systemic Kidney Diseases Liver Diseases
Activity Summary
IC50 22 meas. best 8.74
Kd 8 meas. best 8.35
Ki 1 meas. best 5.51
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 8.74 | 7.3083 | 1.8 | 12 |
| Tyrosine-protein kinase Tec CHEMBL4246 | Kd | 8.35 | 8.35 | 4.5 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | Kd | 8.34 | 8.16 | 4.6 | 3 |
| Tyrosine-protein kinase Tec CHEMBL4246 | IC50 | 7.7 | 7.56 | 20.0 | 2 |
| Cytoplasmic tyrosine-protein kinase BMX CHEMBL3834 | Kd | 7.51 | 7.51 | 31.0 | 1 |
| Receptor tyrosine-protein kinase erbB-4 CHEMBL3009 | IC50 | 7.42 | 7.42 | 37.9 | 1 |
| Cytoplasmic tyrosine-protein kinase BMX CHEMBL3834 | IC50 | 7.42 | 7.42 | 37.9 | 1 |
| TMD8 CHEMBL4296503 | IC50 | 7.25 | 7.25 | 56.2 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.18 | 7.18 | 66.3 | 1 |
| Early activation antigen CD69 CHEMBL3308911 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | Ki | 5.51 | 5.51 | 3100.0 | 1 |
| Tyrosine-protein kinase ITK/TSK CHEMBL2959 | Kd | 5.43 | 5.43 | 3700.0 | 1 |
| Receptor tyrosine-protein kinase erbB-4 CHEMBL3009 | Kd | 5.25 | 5.25 | 5600.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.24 | 5.24 | 5800.0 | 1 |
| Platelet glycoprotein VI CHEMBL3308912 | IC50 | 5.23 | 5.23 | 5840.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | Kd | 5.15 | 5.15 | 7100.0 | 1 |
| ADP-sugar pyrophosphatase CHEMBL4105713 | IC50 | 4.86 | 4.86 | 13900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 110.0 | mL.min-1.g-1 | Homo sapiens |
| Cmax | 52.0 | nM | Mus musculus |
| F | 25.0 | % | Mus musculus |
| F | 5.0 | % | Rattus norvegicus |
| T1/2 | 1.0 | hr | Mus musculus |
| T1/2 | 1.0 | hr | Rattus norvegicus |
| T1/2 | 1.0 | hr | Canis lupus familiaris |
| Tmax | 0.25 | hr | Mus musculus |
| Tmax | 0.25 | hr | Rattus norvegicus |
| Tmax | 0.25 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine